150 related articles for article (PubMed ID: 35633553)
1. Relationship between Bax and Bcl-2 Protein Expression and Outcome of Induction Phase Chemotherapy in Pediatric Acute Lymphoblastic Leukemia.
Cahyadi A; Ugrasena IDG; Andarsini MR; Larasati MCS; Aryati A; Arumsari DK
Asian Pac J Cancer Prev; 2022 May; 23(5):1679-1685. PubMed ID: 35633553
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of BCL2 and BAX following BFM induction therapy predicts ch-ALL patients' poor response to treatment and short-term relapse.
Stamati L; Avgeris M; Kosmidis H; Baka M; Anastasiou T; Piatopoulou D; Scorilas A; Gourgiotis D
J Cancer Res Clin Oncol; 2015 Nov; 141(11):2023-36. PubMed ID: 25982455
[TBL] [Abstract][Full Text] [Related]
3. Relapse in childhood acute lymphoblastic leukemia is associated with a decrease of the Bax/Bcl-2 ratio and loss of spontaneous caspase-3 processing in vivo.
Prokop A; Wieder T; Sturm I; Essmann F; Seeger K; Wuchter C; Ludwig WD; Henze G; Dörken B; Daniel PT
Leukemia; 2000 Sep; 14(9):1606-13. PubMed ID: 10995007
[TBL] [Abstract][Full Text] [Related]
4. Expression of apoptosis regulators Bcl-2 and Bax in childhood acute lymphoblastic leukemia.
Narayan S; Chandra J; Sharma M; Naithani R; Sharma S
Hematology; 2007 Feb; 12(1):39-43. PubMed ID: 17364991
[TBL] [Abstract][Full Text] [Related]
5. Increased BAX expression is associated with an increased risk of relapse in childhood acute lymphocytic leukemia.
Hogarth LA; Hall AG
Blood; 1999 Apr; 93(8):2671-8. PubMed ID: 10194447
[TBL] [Abstract][Full Text] [Related]
6. Mutant p53 protein, Bcl-2/Bax ratios and apoptosis in paediatric acute lymphoblastic leukaemia.
Srinivas G; Kusumakumary P; Nair MK; Panicker KR; Pillai MR
J Cancer Res Clin Oncol; 2000 Jan; 126(1):62-7. PubMed ID: 10641752
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of BAX and BCL-2 Gene Expression and Apoptosis Induction in Acute Lymphoblastic Leukemia Cell Line CCRFCEM after High- Dose Prednisolone Treatment.
Ghasemi A; Khanzadeh T; Zadi Heydarabad M; Khorrami A; Jahanban Esfahlan A; Ghavipanjeh S; Gholipour Belverdi M; Darvishani Fikouhi S; Darbin A; Najafpour M; Azimi A
Asian Pac J Cancer Prev; 2018 Aug; 19(8):2319-2323. PubMed ID: 30141309
[TBL] [Abstract][Full Text] [Related]
8. Clinical relevance of BCL-2 overexpression in childhood acute lymphoblastic leukemia.
Coustan-Smith E; Kitanaka A; Pui CH; McNinch L; Evans WE; Raimondi SC; Behm FG; Aricò M; Campana D
Blood; 1996 Feb; 87(3):1140-6. PubMed ID: 8562940
[TBL] [Abstract][Full Text] [Related]
9. Cellular expression of antiapoptotic BCL-2 oncoprotein in newly diagnosed childhood acute lymphoblastic leukemia: a Children's Cancer Group Study.
Uckun FM; Yang Z; Sather H; Steinherz P; Nachman J; Bostrom B; Crotty L; Sarquis M; Ek O; Zeren T; Tubergen D; Reaman G; Gaynon P
Blood; 1997 May; 89(10):3769-77. PubMed ID: 9160683
[TBL] [Abstract][Full Text] [Related]
10. BCL2L12 improves risk stratification and prediction of BFM-chemotherapy response in childhood acute lymphoblastic leukemia.
Avgeris M; Stamati L; Kontos CK; Piatopoulou D; Marmarinos A; Xagorari M; Baka M; Doganis D; Anastasiou T; Kosmidis H; Gourgiotis D; Scorilas A
Clin Chem Lab Med; 2018 Nov; 56(12):2104-2118. PubMed ID: 30016275
[TBL] [Abstract][Full Text] [Related]
11. Applicability of gene expression profile of childhood acute lymphoblastic leukemia at diagnosis and at the end of the induction phase of chemotherapy at a cancer hospital in the state of Goiás (Brazil).
Minasi LB; Godoy FR; de M e Silva D; Vieira TC; da Silva CC; da Cruz AD
Tumour Biol; 2014 Feb; 35(2):1397-402. PubMed ID: 24052438
[TBL] [Abstract][Full Text] [Related]
12. Effect of Bcl-2-siRNA on proliferation and apoptosis of pediatric acute B lymphoblastic leukemia (A-BLL) cells.
Meng WB; Liu JP; Wang XW; E LH
Genet Mol Res; 2015 Oct; 14(4):12427-36. PubMed ID: 26505392
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of in vitro spontaneous apoptosis by IL-7 correlates with bcl-2 up-regulation, cortical/mature immunophenotype, and better early cytoreduction of childhood T-cell acute lymphoblastic leukemia.
Karawajew L; Ruppert V; Wuchter C; Kösser A; Schrappe M; Dörken B; Ludwig WD
Blood; 2000 Jul; 96(1):297-306. PubMed ID: 10891465
[TBL] [Abstract][Full Text] [Related]
14. Determination of the in vivo effects of prednisone on Bcl-2 family protein expression in childhood acute lymphoblastic leukemia.
Casale F; Addeo R; D'Angelo V; Indolfi P; Poggi V; Morgera C; Crisci S; Di Tullio MT
Int J Oncol; 2003 Jan; 22(1):123-8. PubMed ID: 12469194
[TBL] [Abstract][Full Text] [Related]
15. Amount of spontaneous apoptosis detected by Bax/Bcl-2 ratio predicts outcome in acute myeloid leukemia (AML).
Del Poeta G; Venditti A; Del Principe MI; Maurillo L; Buccisano F; Tamburini A; Cox MC; Franchi A; Bruno A; Mazzone C; Panetta P; Suppo G; Masi M; Amadori S
Blood; 2003 Mar; 101(6):2125-31. PubMed ID: 12424199
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of CD95, Bcl-2 and Bax expression and CD95 function in adult de novo acute myeloid leukemia in context of P-glycoprotein function, maturation stage, and cytogenetics.
Wuchter C; Karawajew L; Ruppert V; Büchner T; Schoch C; Haferlach T; Ratei R; Dörken B; Ludwig WD
Leukemia; 1999 Dec; 13(12):1943-53. PubMed ID: 10602414
[TBL] [Abstract][Full Text] [Related]
17. Diversity of the apoptotic response to chemotherapy in childhood leukemia.
Liu T; Raetz E; Moos PJ; Perkins SL; Bruggers CS; Smith F; Carroll WL
Leukemia; 2002 Feb; 16(2):223-32. PubMed ID: 11840289
[TBL] [Abstract][Full Text] [Related]
18. Mutational analysis of Bax and Bcl-2 in childhood acute lymphoblastic leukaemia.
Salomons GS; Buitenhuis CK; Martínez Muñoz C; Verwijs-Jassen M; Behrendt H; Zsiros J; Smets LA
Int J Cancer; 1998 Jun; 79(3):273-7. PubMed ID: 9645350
[TBL] [Abstract][Full Text] [Related]
19. Bcl-2 protein and apoptosis in pediatric acute lymphoblastic leukemia.
Srinivas G; Kusumakumary P; Nair MK; Panicker KR; Pillai MR
Int J Mol Med; 1998 Apr; 1(4):755-9. PubMed ID: 9852293
[TBL] [Abstract][Full Text] [Related]
20. Elevated expression of the apoptotic regulator Mcl-1 at the time of leukemic relapse.
Kaufmann SH; Karp JE; Svingen PA; Krajewski S; Burke PJ; Gore SD; Reed JC
Blood; 1998 Feb; 91(3):991-1000. PubMed ID: 9446661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
